Run time: 54m

  0      0

2020 AABB Annual Meeting On-Demand

AM20-85: Innovative Cord Blood Derived Therapies


Oct 5, 2020 9:00pm ‐ Oct 5, 2020 9:00pm


Expiration Date: Dec 31, 2022


Credits: None available.

Standard: $25.00
Members: $20.00

Description

As the field and uses of cellular therapies grows, cord blood plays a major role. Cord blood is an amazing source material for innovative products. In this session we will explore some examples, such as NK cells for the treatment of cancer, mesenchymal stem cells for autism, and cell expansion.

Learning Objectives:
  • Explain engineered NK cells derived from cord blood to express chimeric antigen receptor and cytokine genes to enhance their function and persistence in order to treat cancer.
  • Employ knowledge of manufacturing and the potential use of cord blood derived mesenchymal stem cells in the treatment of autism and other diseases.
  • Describe the potential use of ex vivo expanded umbilical cord blood derived stem cells for transplantation.

Speaker(s):

Disclosures

  • Rafet Basar, MD : Grant/Research Support: Affimed; Pharmacyclics; License/research agreement:Taketa
  • Mitchell Horwitz, MD : Consultant: Magenta, Abbie, Mana, Kadmon; Speakers Bureau: Agios; Research/Grant Support: Gamida Cell
  • Joanne Kurtzberg, MD : Research/Grant Support: Marcus Foundation

Credits Available


AM20-85: Innovative Cord Blood Derived Therapies Evaluation

You must be logged in and own this session in order to post comments.